Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06990997 · ClinicalTrials.gov registry record · NA
Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia
A NA study of Aphasia, sponsored by University of Massachusetts, Amherst.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06990997: Recruiting NA study of Aphasia, sponsored by University of Massachusetts, Amherst.
NCT06990997 is a NA study of Aphasia that is actively recruiting participants, run by University of Massachusetts, Amherst. The registered enrollment target is 160 participants, above the 80-participant average among 42 other Aphasia trials with a reported enrollment target (100% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06990997, a NA study of Aphasia, is actively recruiting participants, sponsored by University of Massachusetts, Amherst.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn whether healthy volunteers are more successful at understanding people with aphasia if they have first viewed an aphasia identification (ID) card. The main questions this study aims to answer are: * Does viewing an aphasia ID card improve healthy volunteers' understanding of the language errors made by people with aphasia? * Does viewing an aphasia ID card improve healthy volunteers' understanding of people with aphasia who make long pauses in their speech? Researchers will compare aphasia ID cards to a control condition (no ID card) to see whether aphasia ID cards improve healthy volunteers' understanding. Healthy volunteers will visit the study site for a single session (about 2 hours long). During the session they will: * Complete brief tests of their vision, hearing and thinking * Listen to sentences produced by a speaker with aphasia while their eye movements are recorded * Complete a survey about the experience of listening to the speaker with aphasia
Primary Outcome
Percent correct mouse-click responses on the Service Request Comprehension Task for sentences with long pauses. The Service Request Comprehension Task measures participants' comprehension and processing of language produced by a speaker with aphasia.
Conditions Studied
Interventions
- BEHAVIORAL Aphasia identification (ID) card
Study Locations (1)
Massachusetts
- UMass Amherst Henry M. Thomas III Center at Springfield - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-09-22 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
What NCT06990997 shows while recruiting
NCT06990997 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 80-participant average among 42 other Aphasia trials with a reported enrollment target (100% higher).
The record links to 1 condition, with Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Aphasia identification (ID) card is the first listed.
NCT06990997 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06990997 about?
NCT06990997 is a clinical study titled "Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia". The goal of this clinical trial is to learn whether healthy volunteers are more successful at understanding people with aphasia if they have first viewed an aphasia identification (ID) card. The main questions this study aims to answer are: * Does viewing an aphasia ID card improve healthy voluntee...
What is the current status of trial NCT06990997?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-09-22. Estimated completion is 2026-08-01.
What conditions does trial NCT06990997 study?
This clinical trial studies the following conditions: Aphasia.
What interventions are being tested in trial NCT06990997?
The interventions under investigation include: Aphasia identification (ID) card (BEHAVIORAL).
Who is sponsoring clinical trial NCT06990997?
This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06990997 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06990997's enrollment target sits among peer trials
160 4th of 42 higher than 39 of 42 other Aphasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aphasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Transcranial Alternating Current Stimulation (tACS) in Aphasia
RECRUITING · NA
-
tACS to Enhance Language Abilities
RECRUITING · NA
-
Treatment Outcomes With tDCS in Post-Stroke Aphasia
RECRUITING · NA
-
Telerehabilitation for Aphasia (TERRA)
RECRUITING · NA
-
Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI